We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Portable Device Finds Sepsis Infection Markers

By LabMedica International staff writers
Posted on 20 Jul 2017
A new portable device can quickly find markers of deadly, unpredictable sepsis infection from a single drop of blood, which is the first to provide rapid, point-of-care measurement of the immune system's response, without any need to process the blood.

Sepsis is routinely detected by monitoring patients' vital signs, such as blood pressure, oxygen levels, temperature and others. More...
If a patient shows signs of being septic, the doctors try to identify the source of the infection with blood cultures and other tests that can take days, time the patient may not have. The new device takes a different approach.

Scientists at the University of Illinois at Urbana-Champaign (Urbana, IL, USA) and their colleagues tested the device with blood samples from patients in the intensive care unit (ICU) and emergency room. When a physician suspected infection and ordered a blood test, a small drop of the blood drawn was given to the team, stripped of identifying information to preserve patient confidentiality. The team was able to monitor CD64 levels over time, correlating them with the patient's vital signs. They found that the results from the rapid test correlated well with the results from the traditional tests and with the patients' vital signs. The small, lab-on-a-chip device counts white blood cells in total as well as specific white blood cells called neutrophils, and measures a protein marker called CD64 on the surface of neutrophils. The levels of CD64 surge as the patient's immune response increases.

Rashid Bashir, PhD, a professor of bioengineering and lead investigator, said, “We are looking at the immune response, rather than focusing on identifying the source of the infection. One person's immune system might respond differently from somebody else's to the same infection. In some cases, the immune system will respond before the infection is detectable. This test can complement bacterial detection and identification. We think we need both approaches: detect the pathogen, but also monitor the immune response.”

The team is working to incorporate measurements for other inflammation markers into the rapid-testing device to give a more complete picture of the body's response, and to enable earlier detection. They also have a startup company, Prenosis Inc (Champaign, IL, USA) that is working to commercialize the device. The study was published on July 3, 2017, in the journal Nature Communications.

Related Links:
University of Illinois at Urbana-Champaign
Prenosis

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.